UNITED STATES ANTIMONY CORP (UAMY) Fundamental Analysis & Valuation

NYSE:UAMY • US9115491030

Current stock price

11.18 USD
+1.44 (+14.78%)
At close:
11.1185 USD
-0.06 (-0.55%)
After Hours:

This UAMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. UAMY Profitability Analysis

1.1 Basic Checks

  • In the past year UAMY has reported negative net income.
  • In the past year UAMY has reported a negative cash flow from operations.
  • In the past 5 years UAMY reported 4 times negative net income.
  • UAMY had negative operating cash flow in 4 of the past 5 years.
UAMY Yearly Net Income VS EBIT VS OCF VS FCFUAMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • UAMY has a Return On Assets (-2.82%) which is comparable to the rest of the industry.
  • UAMY's Return On Equity of -3.08% is in line compared to the rest of the industry. UAMY outperforms 51.53% of its industry peers.
Industry RankSector Rank
ROA -2.82%
ROE -3.08%
ROIC N/A
ROA(3y)-10.15%
ROA(5y)-5.93%
ROE(3y)-11.35%
ROE(5y)-6.64%
ROIC(3y)N/A
ROIC(5y)N/A
UAMY Yearly ROA, ROE, ROICUAMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • UAMY's Gross Margin of 25.15% is fine compared to the rest of the industry. UAMY outperforms 60.12% of its industry peers.
  • In the last couple of years the Gross Margin of UAMY has grown nicely.
  • UAMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.64%
GM growth 5Y44.96%
UAMY Yearly Profit, Operating, Gross MarginsUAMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. UAMY Health Analysis

2.1 Basic Checks

  • UAMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, UAMY has more shares outstanding
  • The number of shares outstanding for UAMY has been increased compared to 5 years ago.
  • Compared to 1 year ago, UAMY has an improved debt to assets ratio.
UAMY Yearly Shares OutstandingUAMY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UAMY Yearly Total Debt VS Total AssetsUAMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • UAMY has an Altman-Z score of 64.60. This indicates that UAMY is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 64.60, UAMY belongs to the best of the industry, outperforming 90.18% of the companies in the same industry.
  • UAMY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • UAMY has a better Debt to Equity ratio (0.00) than 79.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 64.6
ROIC/WACCN/A
WACC12.96%
UAMY Yearly LT Debt VS Equity VS FCFUAMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 5.38 indicates that UAMY has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.38, UAMY belongs to the top of the industry, outperforming 81.60% of the companies in the same industry.
  • A Quick Ratio of 4.15 indicates that UAMY has no problem at all paying its short term obligations.
  • UAMY has a better Quick ratio (4.15) than 77.30% of its industry peers.
Industry RankSector Rank
Current Ratio 5.38
Quick Ratio 4.15
UAMY Yearly Current Assets VS Current LiabilitesUAMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. UAMY Growth Analysis

3.1 Past

  • The earnings per share for UAMY have decreased strongly by -120.13% in the last year.
  • Looking at the last year, UAMY shows a very strong growth in Revenue. The Revenue has grown by 162.80%.
  • The Revenue has been growing by 49.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-120.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)162.8%
Revenue growth 3Y52.61%
Revenue growth 5Y49.62%
Sales Q2Q%89.63%

3.2 Future

  • UAMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.59% yearly.
  • The Revenue is expected to grow by 60.51% on average over the next years. This is a very strong growth
EPS Next Y597.25%
EPS Next 2Y248.07%
EPS Next 3Y162.39%
EPS Next 5Y67.59%
Revenue Next Year218.34%
Revenue Next 2Y155.01%
Revenue Next 3Y93.82%
Revenue Next 5Y60.51%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UAMY Yearly Revenue VS EstimatesUAMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
UAMY Yearly EPS VS EstimatesUAMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. UAMY Valuation Analysis

4.1 Price/Earnings Ratio

  • UAMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 56.21, which means the current valuation is very expensive for UAMY.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of UAMY is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of UAMY to the average of the S&P500 Index (22.29), we can say UAMY is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 56.21
UAMY Price Earnings VS Forward Price EarningsUAMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UAMY Per share dataUAMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UAMY's earnings are expected to grow with 162.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y248.07%
EPS Next 3Y162.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UAMY Dividend Analysis

5.1 Amount

  • UAMY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UAMY Fundamentals: All Metrics, Ratios and Statistics

UNITED STATES ANTIMONY CORP

NYSE:UAMY (4/27/2026, 4:16:41 PM)

After market: 11.1185 -0.06 (-0.55%)

11.18

+1.44 (+14.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-19
Earnings (Next)05-20
Inst Owners47.99%
Inst Owner Change0.41%
Ins Owners4.63%
Ins Owner Change-3.52%
Market Cap1.60B
Revenue(TTM)39.26M
Net Income(TTM)-4.35M
Analysts84
Price Target11.14 (-0.36%)
Short Float %23.52%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-217.62%
Min EPS beat(2)-335.25%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-158.81%
Min EPS beat(4)-335.25%
Max EPS beat(4)-100%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-13.15%
Min Revenue beat(2)-33.66%
Max Revenue beat(2)7.35%
Revenue beat(4)2
Avg Revenue beat(4)-9.99%
Min Revenue beat(4)-33.66%
Max Revenue beat(4)7.35%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.93%
EPS NQ rev (1m)-81.25%
EPS NQ rev (3m)-83.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.36%
Revenue NQ rev (1m)-43.08%
Revenue NQ rev (3m)-17.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 56.21
P/S 40.83
P/FCF N/A
P/OCF N/A
P/B 11.37
P/tB 11.37
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.2
Fwd EY1.78%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.27
BVpS0.98
TBVpS0.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.82%
ROE -3.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.15%
FCFM N/A
ROA(3y)-10.15%
ROA(5y)-5.93%
ROE(3y)-11.35%
ROE(5y)-6.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.64%
GM growth 5Y44.96%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2383.72%
Cap/Sales 70.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.38
Quick Ratio 4.15
Altman-Z 64.6
F-Score4
WACC12.96%
ROIC/WACCN/A
Cap/Depr(3y)860.9%
Cap/Depr(5y)569.23%
Cap/Sales(3y)30.43%
Cap/Sales(5y)23.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y597.25%
EPS Next 2Y248.07%
EPS Next 3Y162.39%
EPS Next 5Y67.59%
Revenue 1Y (TTM)162.8%
Revenue growth 3Y52.61%
Revenue growth 5Y49.62%
Sales Q2Q%89.63%
Revenue Next Year218.34%
Revenue Next 2Y155.01%
Revenue Next 3Y93.82%
Revenue Next 5Y60.51%
EBIT growth 1Y-273.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.63%
EBIT Next 3Y85.45%
EBIT Next 5Y43.24%
FCF growth 1Y-2195.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-536.47%
OCF growth 3YN/A
OCF growth 5YN/A

UNITED STATES ANTIMONY CORP / UAMY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UNITED STATES ANTIMONY CORP?

ChartMill assigns a fundamental rating of 4 / 10 to UAMY.


What is the valuation status of UNITED STATES ANTIMONY CORP (UAMY) stock?

ChartMill assigns a valuation rating of 2 / 10 to UNITED STATES ANTIMONY CORP (UAMY). This can be considered as Overvalued.


How profitable is UNITED STATES ANTIMONY CORP (UAMY) stock?

UNITED STATES ANTIMONY CORP (UAMY) has a profitability rating of 2 / 10.


Can you provide the financial health for UAMY stock?

The financial health rating of UNITED STATES ANTIMONY CORP (UAMY) is 6 / 10.


Can you provide the dividend sustainability for UAMY stock?

The dividend rating of UNITED STATES ANTIMONY CORP (UAMY) is 0 / 10 and the dividend payout ratio is 0%.